Alere Recalls 803,000 Tests for Heart Attacks

Alere Inc. is recalling 803,000 tests used to detect heart attacks and manage heart failure patients that failed to meet quality control guidelines.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.